Sanctuary Advisors LLC acquired a new position in Tiziana Life Sciences Ltd (NASDAQ:TLSA – Free Report) during the third quarter, Holdings Channel reports. The institutional investor acquired 907,613 shares of the company’s stock, valued at approximately $864,000.
Separately, Zhang Financial LLC boosted its holdings in Tiziana Life Sciences by 24.2% in the 3rd quarter. Zhang Financial LLC now owns 69,387 shares of the company’s stock valued at $67,000 after purchasing an additional 13,500 shares during the period.
Tiziana Life Sciences Trading Down 6.9 %
NASDAQ TLSA opened at $0.78 on Monday. Tiziana Life Sciences Ltd has a twelve month low of $0.41 and a twelve month high of $1.74. The firm has a 50-day simple moving average of $0.95 and a 200 day simple moving average of $0.97.
Tiziana Life Sciences Profile
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.
See Also
- Five stocks we like better than Tiziana Life Sciences
- 3 Small Caps With Big Return Potential
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- CarMax Gets in Gear: Is Now the Time to Buy?
- How to Use the MarketBeat Dividend Calculator
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Want to see what other hedge funds are holding TLSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tiziana Life Sciences Ltd (NASDAQ:TLSA – Free Report).
Receive News & Ratings for Tiziana Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tiziana Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.